Filing Details
- Accession Number:
- 0001415889-24-010689
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-11 16:30:09
- Reporting Period:
- 2024-04-09
- Accepted Time:
- 2024-04-11 16:30:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-09 | 15,000 | $129.49 | 15,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-09 | 6,994 | $236.74 | 8,136 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-09 | 8,006 | $237.52 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-04-10 | 13,800 | $129.49 | 13,930 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-10 | 208 | $233.09 | 13,722 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-10 | 102 | $234.26 | 13,620 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-10 | 527 | $235.69 | 13,093 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-10 | 1,732 | $236.73 | 11,361 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-10 | 1,291 | $237.68 | 10,070 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-10 | 9,940 | $237.52 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-04-09 | 15,000 | $0.00 | 15,000 | $129.49 |
| Common Stock | Stock Options | Disposition | 2024-04-10 | 13,800 | $0.00 | 13,800 | $129.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 352,469 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
| 338,669 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $236.09 to $237.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $237.10 to $238.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $232.735 to $233.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $234.055 to $234.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $235.19 to $236.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $236.38 to $237.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $237.45 to $237.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
